Hanlin L. Wang, MD, PhD

Hanlin L. Wang, MD

Professor, Department of Pathology and Laboratory Medicine

Specialty

Pathology

Institutional Affiliation

Ronald Reagan UCLA Medical Center

Languages

English, Chinese - Mandarin

Education

Fellowship

GI/Liver Pathology, University of Chicago Hospitals, 2000 - 2001

Degree

MD, Wuhan University School of Medicine, 1982

Residency

Anatomic and Clinical Pathology, University of Chicago Hospitals, 1996 - 2000

Board Certification

Anatomic Pathology and Clinical Pathology, American Board of Pathology, 2000

Contact Information

Clinical Interests

Diagnostic Pathology of Gastrointestinal Diseases, Diagnostic Pathology of Hepatobiliary Diseases, Diagnostic Pathology of Pancreatic Diseases

Scientific Interests

Dr. Hanlin Wang is interested in diagnostic, therapeutic and prognostic biomarkers of gastrointestinal, hepatobiliary and pancreatic diseases.

Highlighted Publications

Fleming M, Ravula S, Tatishchev SF, Wang HL. Colorectal carcinoma: Pathologic aspects. J Gastrointest Oncol. 2012 Sep;3(3):153-73. doi: 10.3978/j.issn.2078-6891.2012.030.

Levy M, Trivedi A, Zhang J, Miles L, Mattis AN, Kim GE, Lassman C, Anders RA, Misdraji J, Yerian LM, Xu H, Dhall D, Wang HL. Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Hum Pathol. 2012 May;43(5):695-701. doi: 10.1016/j.humpath.2011.06.016. Epub 2011 Sep 19.

Fan L, Levy M, Aguilar CE, Mertens RB, Dhall D, Frishberg DP, Wang HL. Lymph node retrieval from colorectal resection specimens for adenocarcinoma: is it worth the extra effort to find at least 12 nodes? Colorectal Dis. 2011 Dec;13(12):1377-83. doi: 10.1111/j.1463-1318.2010.02472.x.

Wang HL, Lopategui J, Amin MB, Patterson SD. KRAS mutation testing in human cancers: The pathologist's role in the era of personalized medicine. Adv Anat Pathol. 2010 Jan;17(1):23-32. doi: 10.1097/PAP.0b013e3181c6962f.

Fan L, Mac MT, Frishberg DP, Fan X, Dhall D, Balzer BL, Geller SA, Wang HL. Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. J Gastroenterol Hepatol. 2010 Sep;25(9):1556-61. doi: 10.1111/j.1440-1746.2010.06304.x.